Suchergebnisse - "Svane, Inge Marie"

PubPharm (413)

1

Frequency and characteristics of immune-related thyroid adverse events in patients with resected stage III/IV melanoma treated with adjuvant PD-1 inhibitors : a national cohort study

enthalten in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | 2024

von Christensen, S. | Winther, M. | Laursen, I. | +12

2

Frequency and characteristics of immune-related thyroid adverse events in patients with resected stage III/IV melanoma treated with adjuvant PD-1 inhibitors: a national cohort study

enthalten in: Supportive care in cancer | 2024

von Christensen, S. | Winther, M. | Laursen, I. | +12

3

Molecular patterns of resistance to immune checkpoint blockade in melanoma

enthalten in: Nature communications | 2024

von Lauss, M. | Phung, B. | Borch, T. | +13

4

Outcome of adjuvant immunotherapy in a real-world nation-wide cohort of patients with melanoma

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Holmstroem, R. | Pedersen, S. | Jurlander, R. | +8

5

Identification and characterization of neoantigen-reactive CD8+ T cells following checkpoint blockade therapy in a pan-cancer setting

enthalten in: bioRxiv.org | 2024

von Moss, K. | Hansen, U. | de Lima, V. | +10

6

Harnessing neoantigen-specific T cells for precision cancer immunotherapy

enthalten in: Nature reviews. Clinical oncology | 2024

von Donia, M. | Svane, I.

7

Prospective Assessment of Fluorine-18-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography (FDG-PET/CT) for Early Identification of Checkpoint-Inhibitor-Induced Pseudoprogression

enthalten in: Cancers | 2024

von Homburg, S. | Christensen, C. | Pedersen, M. | +5

8

PD-L1 is a biomarker of real-world clinical outcomes for anti-CTLA-4 plus anti-PD-1 or anti-PD-1 monotherapy in metastatic melanoma

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Ellebaek, E. | Khan, S. | Bastholt, L. | +4

9

enthalten in: Ugeskrift for laeger | 2024

von Storgaard, L. | Brix-Tange, U. | Colmorn, L. | +18

10

IMPROVE : a feature model to predict neoepitope immunogenicity through broad-scale validation of T-cell recognition

enthalten in: Frontiers in immunology | 2024

von Borch, A. | Carri, I. | Reynisson, B. | +20

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[42]